Log In
BCIQ
Print this Print this
 

R1MAb

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionAgonistic mAb targeting fibroblast growth factor (FGF) receptor 1 (FGFR1; CD331)
Molecular Target Fibroblast growth factor (FGF) receptor 1 (FGFR1) (CD331)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerRoche

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today